Gysin et al. showed that pharmacologic inhibition of RAF-MEK-ERK signaling in pancreatic cancer cells inhibits cell growth and results in G1 cell-cycle arrest through induced expression of p27Kip1[49]. The gene discussed is CDKN1B; the disease is familial pancreatic carcinoma.